Table 4. Total fatty acid composition of plasma from control subjects and PCOS patients.

	Control			PCOS			P value
C14:0	0.401	±	0.023	0.608	±	0.054	0.001
C16:0	20.563	±	0.469	21.553	±	0.370	0.130
C16:1n-7	1.149	±	0.093	1.351	±	0.130	0.203
C18:0	7.967	±	0.496	8.319	±	0.128	0.559
C18:1n-9	20.615	±	0.391	20.336	±	0.628	0.694
C18:1n-7	1.797	±	0.052	1.746	±	0.046	0.514
C18:2n-6	32.502	±	0.774	32.123	±	1.033	0.767
C18:3n-3	0.309	±	0.017	0.314	±	0.036	0.881
C18:4n-3	0.205	±	0.007	0.140	±	0.006	0.001
C20:0	0.302	±	0.013	0.160	±	0.006	0.001
C20:1n-9	0.276	±	0.013	0.232	±	0.009	0.019
C20:2n-6	0.067	±	0.009	0.041	±	0.003	0.031
C20:3n-6	1.502	±	0.080	1.405	±	0.086	0.425
C20:4n-6	6.626	±	0.300	6.534	±	0.365	0.847
C20:5n-3	0.055	±	0.004	0.043	±	0.003	0.034
C22:0	0.278	±	0.011	0.271	±	0.008	0.680
C22:1n-9	2.355	±	0.259	2.214	±	0.213	0.694
C22:4n-6	0.238	±	0.009	0.180	±	0.008	0.001
C22:5n-6	0.118	±	0.008	0.156	±	0.026	0.127
C22:5n-3	0.377	±	0.033	0.282	±	0.022	0.038
C24:0	0.055	±	0.004	0.128	±	0.017	0.001
C22:6n-3	1.615	±	0.085	1.518	±	0.115	0.493
C24:1n-9	0.387	±	0.017	0.283	±	0.011	0.001
C26:0	0.244	±	0.014	0.043	±	0.006	0.001
ACL	17.972	±	0.021	17.899	±	0.018	0.019
SFA	29.808	±	0.492	31.093	±	0.416	0.069
UFA	70.192	±	0.492	68.906	±	0.416	0.069
MUFA	26.577	±	0.507	26.163	±	0.654	0.616
PUFA	43.615	±	0.657	42.742	±	0.789	0.401
PUFAn3	2.562	±	0.100	2.303	±	0.156	0.154
PUFAn6	41.053	±	0.706	40.439	±	0.851	0.582
DBI	137.867	±	1.202	134.605	±	1.151	0.068
PI	81.355	±	1.275	78.730	±	1.371	0.178
AI	49.801	±	3.379	46.676	±	2.755	0.504

Abbreviations: ACL, average chain length; SFA, saturated fatty acids; UFA, unsaturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; PUFAn-3, polyunsaturated fatty acids series n-3; PUFAn-6, polyunsaturated fatty acids series n-6; DBI, double bond index; PI, peroxidizability index; AI, anti-inflammatory index.